Michael R. Jaff, DO - Gilde Healthcare

team
Venture&Growth

All team members
Michael R. Jaff, DO
Operational Partner
United States of America

Michael R. Jaff, DO

Operational Partner

Michael R. Jaff, DO is the Chief Medical Officer and Vice-President of clinical affairs, technology and innovation at Boston Scientific Corporation. A professor of medicine at Harvard Medical School, Dr. Jaff was the President of Newton-Wellesley Hospital from October 2016-December 2019. Prior to that, Dr. Jaff was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital. He is an expert in all aspects of vascular medicine, including peripheral artery disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine.

He is the founder of VasCore, the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. VasCore has participated in trial design and independent analysis of vascular laboratory images for over 200 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries.

Dr. Jaff has published extensively in the field of Vascular Medicine with over 300 peer-reviewed publications and 10 textbooks, is the Past-President of the Society for Vascular

Medicine and Biology and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention, and is a registered physician in vascular interpretation (RPVI).

In November 2011, Dr. Jaff became an alumnus of Harvard Business School after completing the General Management Program.

Edward Hanlon

Associate Healthtech
Venture&Growth
Edward Hanlon joined Gilde Healthcare in 2020 in the Cambridge office and focuses on Healthtech. Prior to joining Gilde, Edward worked in advisory for Health Advances, a consulting firm operating across healthcare sectors in medical...

Dan Secor

Associate Healthtech
Venture&Growth
Dan Secor joined Gilde Healthcare in 2020 in the Cambridge office and focuses on the Healthtech sector. He was part of Gilde’s investment team in Eargo, where he served as a board observer. Before joining...

Janke Dittmer

General Partner Healthtech
Venture&Growth
Janke Dittmer joined Gilde in 2011 as a Partner. He led Gilde's investment in Definiens (acquired by AZ), Sapiens (acquired by Medtronic), Volta Medical, Big Health, FIRE1, Lumeon and Nyxoah and was involved in several...